Project Number 291003 VEN-Wustman-2009 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2009 View Full Project Details for Modulation of Ganglioside Catabolism Using Pharmacological Chaperones: A Novel Therapeutic Approach for Treating Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) i. Proteostasis/Proteinopathies Researcher and Organization Principal Investigator Wustman, Brandon Principal Investigator First Name Brandon Principal Investigator Last Name Wustman Awardee Organization Amicus Therapeutics Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement General RFP FY Overall Cost $210,300 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
